Palisade Bio Inc Stock Ownership - Who owns Palisade Bio?

Insider buying vs selling

Have Palisade Bio Inc insiders been buying or selling?
John David FinleyCEO CFO Director2023-04-03435$2.01
Robert Curtis McRaeChief Operating Officer2023-04-03270$2.00
John David FinleyChief Financial Officer2022-09-0119,481$0.14
John David FinleyChief Financial Officer2022-08-237,350$0.16
John David FinleyChief Financial Officer2022-08-16100,000$0.25
Thomas HallamChief Executive Officer2022-08-1640,000$0.25

1 of 1

PALI insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when PALI insiders and whales buy or sell their stock.

PALI Shareholders

What type of owners hold Palisade Bio Inc stock?
Richard Garr29.66%1,986,304$2.76MInsider
Regional Medical Center Yuma27.09%1,814,375$2.52MInsider
Princeton Capital Corp19.32%1,293,814$1.80MInsider
Stanley Westreich17.82%1,193,281$1.66MInsider
Karl Johe13.89%930,373$1.29MInsider
Robert J. Trenschel4.77%319,478$444.07kInsider
Sandford D. Smith3.28%219,916$305.68kInsider
John Conron1.72%115,492$160.53kInsider
Catherine A. Sohn1.60%106,952$148.66kInsider
Scott Varde Ogilvie1.28%86,020$119.57kInsider

1 of 3

PALI vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
PALI0.10%99.90%Net BuyingNet Selling
PSTV7.94%92.06%Net BuyingNet Buying
CYCN68.37%31.63%Net BuyingNet Buying
CNSP2.44%97.56%Net BuyingNet Buying

Palisade Bio Stock Ownership FAQ

Who owns Palisade Bio?

Palisade Bio (NASDAQ: PALI) is owned by 0.13% institutional shareholders, 123.13% Palisade Bio insiders, and 0.00% retail investors. Richard Garr is the largest individual Palisade Bio shareholder, owning 1.99M shares representing 29.66% of the company. Richard Garr's Palisade Bio shares are currently valued at $2.82M.

If you're new to stock investing, here's how to buy Palisade Bio stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.